Electrochemical chiral sensor for recognition of amino acid enantiomers with cyclodextrin-based microporous organic networks
Analytica Chimica Acta · 2024-08 · 1316 · 342879
DOI: 10.1016/j.aca.2024.342879 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024-08. Verfasst von Xuan Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University and Wuhan University, School of Pharmaceutical Sciences, Wuhan, 4…. Hauptthemen laut MEDLINE: Electrochemical Techniques, Cyclodextrins. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Chirality is a ubiquitous phenomenon in nature, but enantiomers exhibit different pharmacological activities and toxicological effects. Therefore, Chiral recognition plays a pivotal role in various fields such as life sciences, chemical synthesis, drug development, and materials science. The synthesis of novel chiral composites with well-defined loading capabilities and ordered structures holds significant potential for electrochemical chiral recognition applications. However, the design of selective and stable electrochemical chiral recognition materials remains a challenging task. RESULT: In this work, we construct a simple and rapid electrochemical sensing platform for tryptophan (Trp) enantiomer recognition using cyclodextrin-modified microporous organic network as chiral recognition agent. CD-MON with chiral microenvironment was prepared by Sonogashira-Hagihara coupling reaction of the chiral molecule heptyl-6-iodo-6-deoxyβ-cyclodextrin and 1, 4-Diethynylbenzene. The adhesion of BSA makes CD-MON firmly fixed on the electrode surface, and as a chiral protein, it can improve the chiral recognition ability through synergistic effect. Chiral amino acids are in full contact with the chiral microenvironment during pore conduction of MON, and L-Trp is more stably bound to CD-MON/BSA due to steric hindrance, host-guest recognition and hydrogen bonding. Therefore, the electrochemical sensor can effectively identify tryptophan enantiomers (IL-Trp/ID-Trp = 2.02), and it exhibits a detection limit of 2.6 μM for L-Trp. UV-Vis spectroscopy confirmed the adsorption capacity of CD-MON towards tryptophan enantiomers in agreement with electrochemistry results. SIGNIFICANCE: The prepared chiral sensor has excellent stability, reproducibility (RSD = 3.7%) and selectivity, realizes the quantitative detection of single isomer in tryptophan racemic and quantitative analysis in real samples with 94.0%-101.0% recovery. This work represents the first application of MON in chiral electrochemistry which expands the application scope of chiral sensors and holds great significance in separation science and electrochemical sensing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University and Wuhan University, School of Pharmaceutical Sciences, Wuhan, 430071, China; Key Laboratory of Combinatorial Biosynthesis and Drug Di…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Wang, F., & Chen, Z. (2024). Electrochemical chiral sensor for recognition of amino acid enantiomers with cyclodextrin-based microporous organic networks. Analytica Chimica Acta, 1316, 342879. https://doi.org/10.1016/j.aca.2024.342879
Vancouver
Zhang X, Wang F, Chen Z. Electrochemical chiral sensor for recognition of amino acid enantiomers with cyclodextrin-based microporous organic networks. Analytica Chimica Acta. 2024;1316:342879. doi:10.1016/j.aca.2024.342879
BibTeX
@article{Zhang2024,
author = {Zhang, Xuan and Wang, Fang and Chen, Zilin},
title = {Electrochemical chiral sensor for recognition of amino acid enantiomers with cyclodextrin-based microporous organic networks},
journal = {Analytica Chimica Acta},
year = {2024},
volume = {1316},
pages = {342879},
doi = {10.1016/j.aca.2024.342879}
}
EUVIMED